Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167544 · ClinicalTrials.gov registry record · Phase 2
Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
A Phase 2 study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 64
- Enrollment target
NCT00167544 is a Phase 2 study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 64 participants.
The verdict
NCT00167544, a Phase 2 study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether treatment of very preterm infants at high-risk for lung and brain injury with low dose hydrocortisone results in improved pulmonary and neurologic outcomes.
Interventions
- DRUG Placebo
- DRUG Hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2005-11 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167544
The ClinicalTrials.gov registry entry for NCT00167544 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00167544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00167544 about?
NCT00167544 is a clinical study titled "Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants". The purpose of this study is to determine whether treatment of very preterm infants at high-risk for lung and brain injury with low dose hydrocortisone results in improved pulmonary and neurologic outcomes.
What is the current status of trial NCT00167544?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 64 participants. The study started on 2005-11. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00167544?
The interventions under investigation include: Placebo (DRUG), Hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT00167544?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.